Skip to main content

Day: August 30, 2021

Bio Power Market worth USD 86.17 Billion by 2028, registering a CAGR of 6.41% – Report by Market Research Future (MRFR)

New York, Aug. 30, 2021 (GLOBE NEWSWIRE) — Bio Power Market Overview: According to a comprehensive research report by Market Research Future (MRFR), “Bio Power Market Research Report, by Technology, End-User and Region – Forecast till 2027” the market is projected to be worth USD 86.17 Billion by 2028, registering a CAGR of 6.41% during the forecast period (2021 – 2028)., The market was valued at USD 51.7 Billion in 2020. Competitive Analysis List of the Key Companies Profiled in the Bio Power Market Research Report are–EnviTec Biogas AG (Germany) Dalkia (France) Schmack Biogas GmbH (Germany) Ørsted A/S (Denmark) WELTEC Biopower GMBH (Germany) ElectraTherm (Georgia) Ameresco (US) Babcock & Wilcox Enterprises Inc. (US) Enerkem (Canada) MVV Energie AG (Germany)Get Free Sample PDF Brochure https://www.marketresearchfuture.com/sample_request/1512 The...

Continue reading

ABVC BioPharma Report Updated by Zacks/SCR

FREMONT, CA, Aug. 30, 2021 (GLOBE NEWSWIRE) — via NewMediaWire – ABVC BioPharma, Inc. (NASDAQ: ABVC), a clinical stage biopharmaceutical company developing therapeutic solutions in oncology/hematology, CNS, and ophthalmology, today announced that Zacks Small Cap Research has issued an update report on the company which may be accessed at: https://scr.zacks.com/news/news-details/2021/ABVC-Company-Continues-to-Advance-Lead-Assets–Earlier-Stage-Candidates-/default.aspx. About ABVC BioPharma ABVC BioPharma is a clinical-stage biopharmaceutical company with an active pipeline of six drugs and one medical device (ABV-1701/Vitargus®) under development. For its drug products, it is focused on utilizing its licensed technology to conduct proof-of-concept trials through Phase II of the clinical development process at world-famous research...

Continue reading

Quisitive Announces BMO Credit Facility and Retires Existing Credit Facility

TORONTO, Aug. 30, 2021 (GLOBE NEWSWIRE) — Quisitive Technology Solutions Inc. (“Quisitive” or the “Company”) (TSXV: QUIS), a premier Microsoft Cloud Services and Payment Solutions Provider, is pleased to announce that it has paid out and retired its existing credit facility with a Canadian Schedule 1 Chartered Bank (the “Bank”) and has entered into a new credit facility with a syndicate led by Bank of Montreal (“BMO”) and including Desjardins Capital Markets (“DCM”) pursuant to the terms of a loan agreement entered into between the Company, certain material subsidiaries of the Company, as guarantors, BMO, as administrative agent (“BMO”) and the lenders party thereto (the “Lenders”) dated August [27], 2021 (the “Loan Agreement”). The Loan Agreement provides for a five-year term loan of US$70,000,000 (the “Term Loan”)...

Continue reading

Auto Parts 4Less Group, Inc. (FLES) Launches AutoParts4Less.com

AutoParts4Less.com is a stand-alone multi-vendor online marketplace dedicated entirely to the sale of automotive parts Las Vegas, NV, Aug. 30, 2021 (GLOBE NEWSWIRE) — The 4Less Group, Inc. (OTCQB: FLES)(“4Less”,”Company”) today announced they’ve launched a MVP (Minimal Viable Product) version of autoparts4less.com website on August 26th, the newest 4Less business enterprise, which joins LiftsKits4Less.com under the 4LessGroup umbrella. The 4Less automotive marketplace is a platform created entirely for a diverse group of trusted sellers from across the world to market and sell a wide range of automotive equipment for cars, trucks, motorcycles, boats and RVs. Approved sellers will include auto parts retailers, warehouse distributors, and manufacturers for cars, trucks, commercial vehicles and specialty vehicles such as motorcycles,...

Continue reading

Daxor Corporation Reports a 26.5 Percent Rise in Diagnostic Sales Revenue in Form N-CSR Filing for the Six Months Ended June 30, 2021

Company forecasts further increase in sales driven by new distributor agreements Oak Ridge, TN, Aug. 30, 2021 (GLOBE NEWSWIRE) — Daxor Corporation (NYSE: DXR), the global leader in blood volume measurement technology, announces today it filed Form N-CSR disclosing its schedule of portfolio holdings for the six months ended June 30, 2021. The Company’s increase in revenue of 26.5% in the Company’s diagnostic division, represents strong strides in the commercialization of its BVA-100® Blood Volume Analyzer and eight additional accounts. In addition, the filing noted that Daxor’s next-generation point-of-care analyzers utilizing patent-pending fluorescence technology are on track for production as funded by the U.S. Department of Defense and slated for release in 2022. Updates on the initiation of a National Institutes of Health multicenter...

Continue reading

iFresh Announces Exclusive Agency Agreement with Bit Farm Inc.

NEW YORK, Aug. 30, 2021 (GLOBE NEWSWIRE) — iFresh, Inc. (“iFresh” or the “Company”) (Nasdaq: IFMK), a leading Asian American grocery supermarket chain and online grocer, today announced that the Company has entered into an exclusive agency agreement (“Agreement”) with Bit Farm Inc. This agreement names iFresh as the exclusive distributor of Bit Silica + ® (“Bit Silica Plus”), a fertilizer that promotes plant growth. iFresh is authorized to market and sell Bit Silica Plus in the United States for the next twelve months, with an option to extend. Bit Farm Inc., incorporated in Florida, focuses in the technology sector, with operations in agriculture (including cannabis) and digital currency mining. Bit Farm has developed Bit Silica Plus to accelerate plant growth and extend harvest time. The plant supplement corrects common plant...

Continue reading

Stryker to participate in Morgan Stanley’s 19th Annual Global Healthcare Conference

Kalamazoo, Michigan, Aug. 30, 2021 (GLOBE NEWSWIRE) — Stryker (NYSE:SYK) will participate in Morgan Stanley’s 19th Annual Global Healthcare Conference on Monday, September 13, 2021. Kevin Lobo, Chair and Chief Executive Officer, will represent the Company in a virtual presentation scheduled for 10:15 a.m. Eastern Time. A simultaneous webcast and replay of the Company’s presentation will be available on Stryker’s website at www.stryker.com. The webcast will be archived on the Investor Relations page of this site. Stryker is one of the world’s leading medical technology companies and, together with its customers, is driven to make healthcare better. The company offers innovative products and services in Orthopaedics, Medical and Surgical, and Neurotechnology and Spine that help improve patient and hospital outcomes....

Continue reading

Acer Therapeutics to Participate in H.C. Wainwright 23rd Annual Global Investment Conference

NEWTON, Mass., Aug. 30, 2021 (GLOBE NEWSWIRE) — Acer Therapeutics Inc. (Nasdaq: ACER), a pharmaceutical company focused on the acquisition, development and commercialization of therapies for serious rare and life-threatening diseases with significant unmet medical needs, today announced that Acer’s management team will present and host one-on-one investor meetings at the upcoming H.C. Wainwright Global Investment Conference September 13-15, 2021.     Conference:   H.C. Wainwright 23rd Annual Global Investment ConferenceFormat:   Virtual on demand presentation and one-on-one meetingsPresentation:   Available on demand beginning September 13, 2021 at 7 AM ETWebcast:   https://www.acertx.com/investor-relations/events-presentations/     About Acer Therapeutics Inc.Acer is a pharmaceutical company focused on the...

Continue reading

LifeMD Partners With Prescryptive Health, Expanding Convenience and Affordability for Patients

Strategic partnership provides LifeMD with a vertically integrated, best-in-class pharmacy fulfillment and e-prescribing technology platform and immediate access to nationwide pharmacy network NEW YORK, Aug. 30, 2021 (GLOBE NEWSWIRE) — LifeMD, Inc. (NASDAQ: LFMD), a leading direct-to-patient telehealth company, today announced its strategic partnership with Prescryptive Health (Prescryptive), a healthcare technology company empowering consumers by improving the way healthcare is delivered. The partnership is expected to accelerate growth for both companies by combining LifeMD’s expanding direct-to-patient telehealth brands and soon-to-launch primary care platform with Prescryptive’s best-in-class digital pharmacy fulfillment and e-prescribing technology platform. The partnership will enable LifeMD to:Leverage a nationwide network...

Continue reading

Edge Computing Market to Gain Considerable Traction; NVIDIA Launches NVIDIA EGX, Its AI-enabled Edge Computing Platform for Diverse Industries: Fortune Business Insights™

List of Key Players Covered in the Edge Computing Market Report: Dell Technologies, IBM Corporation, Huawei Technologies Co. Ltd., General Electric Company, Telefonaktiebolaget LM Ericsson, Oracle Corporation, Microsoft Corporation, Intel Corporation, Cisco Systems, Inc., Amazon Web Services (AWS), Inc. Pune, India, Aug. 30, 2021 (GLOBE NEWSWIRE) — The global edge computing market size is poised to experience dynamic expansion on account of the promising growth of edge computing startups around the world, observes Fortune Business Insights™ in its report, titled “Edge Computing market size, share & industry analysis, By Component (Hardware, Software, Services), By Enterprise Size (SMEs, Large Enterprise), By Vertical (BFSI, Transportation, Healthcare, Manufacturing, Semiconductor, Government, IT & Telecommunication, Retail,...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.